Affiliation:
1. Hebrew University of Jerusalem
2. The Hebrew University of Jerusalem
3. The Hebrew University
4. National Institute of Biological Sciences, Beijing
5. National Institute of Biological Sciences
6. Hebrew University
Abstract
Abstract
While the activities of certain proteases promote proteostasis and prevent neurodegeneration-associated phenotypes, the protease cathepsin B (CTSB) enhances proteotoxicity in Alzheimer’s disease (AD) model mice, and its levels are elevated in brains of AD patients. How CTSB exacerbates the toxicity of the AD-causing Amyloid β (Aβ), is controversial. Using an activity-based probe, aging-altering interventions and the nematode C. elegans we discovered that the CTSB CPR-6 promotes Aβ proteotoxicity but mitigates the toxicity of polyQ stretches. While the knockdown of cpr-6 does not affect lifespan, it alleviates Aβ toxicity by reducing the expression of swsn-3 and elevating the level of the protein SMK-1, both involved in the regulation of aging. These observations unveil a novel mechanism by which CTSB aggravates Aβ–mediated toxicity, indicate that it plays opposing roles in the face of distinct proteotoxic insults and highlight the importance of tailoring specific remedies for distinct neurodegenerative disorders.
Publisher
Research Square Platform LLC
Reference52 articles.
1. The biology of proteostasis in aging and disease;Labbadia J;Annual review of biochemistry,2015
2. Jayaraj GG, Hipp MS, Hartl FU. Functional Modules of the Proteostasis Network. Cold Spring Harb Perspect Biol. 2019.
3. Gidalevitz T, Ben-Zvi A, Ho KH, Brignull HR, Morimoto RI. Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science (New York, NY. 2006;311(5766):1471–4.
4. Protein Quality Control in Health and Disease;Dubnikov T;Cold Spring Harb Perspect Biol,2017
5. Protein fate in neurodegenerative proteinopathies: polyglutamine diseases join the (mis)fold;Paulson HL;Am J Hum Genet,1999